Introduction & Pipeline
Introduction & Pipeline
Introduction
PharmaResearch Bio is specializing in botulinum toxin drugs as its main product line.
PharmaResearch Bio's core competencies include botulinum toxin plantation, separation/purification, and formulation technology.
Such competencies will be at the center of everything we do for the discovery and further research on bio-friendly products using natural polymers
and new raw materials.
We believe that such efforts will eventually bring us differentiated competitiveness within the aesthetic market.
Pipeline
Pharmaceuticals
Code | PIPE LINE |
Indication | Discovery Research |
Preclinical trial |
Clinical trial |
NDA | Launching |
---|---|---|---|---|---|---|---|
BCD 200 |
Botulinum
Toxin |
Aesthetic |
|
||||
Therapeutics |
|
||||||
PRB 004 |
Botulinum Toxin (liquid-type) |
Aesthetic |
|
||||
PRB 002 |
Botulinum Toxin (150kDa) |
Aesthetic |
|
||||
PRB 005 |
Next Botulinum Toxin |
Aesthetic |
|